Your browser doesn't support javascript.
loading
Cerebral venous thrombosis in adults: a case series of 35 patients from a tertiary hospital.
Galeano-Valle, F; Oblitas, Crhistian-Mario; González-San-Narciso, C; Esteban-San-Narciso, B; Lafuente-Gómez, G; Demelo-Rodríguez, P.
Afiliación
  • Galeano-Valle F; Unidad de Enfermedad Tromboembólica Venosa, Medicina Interna, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
  • Oblitas CM; Unidad de Enfermedad Tromboembólica Venosa, Medicina Interna, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Electronic address: christian.amodeo@iisgm.com.
  • González-San-Narciso C; Unidad de Enfermedad Tromboembólica Venosa, Medicina Interna, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Esteban-San-Narciso B; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
  • Lafuente-Gómez G; Servicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Demelo-Rodríguez P; Unidad de Enfermedad Tromboembólica Venosa, Medicina Interna, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
Rev Clin Esp (Barc) ; 223(7): 423-432, 2023.
Article en En | MEDLINE | ID: mdl-37343816
OBJECTIVE: To describe the baseline characteristics, clinical presentation, imaging tests and outcomes, and identify potential prognostic factors in a cohort of patients diagnosed with cerebral venous thrombosis (CVT). PATIENTS AND METHODS: This retrospective, single-center, observational study included adult patients diagnosed with CVT from January 2016 to December 2020. The variables were reviewed using electronic medical records. RESULTS: A total of 35 patients were included, with a median age at diagnosis of 50.3 (+/- 17.8) years, and the majority being women (74.4%). Nearly 95% of the patients presented at least one risk factor for the development of CVT. Heparins were used for the acute phase in 97.1% of cases, with 75% of those being low molecular weight heparins.During the first two weeks, a compound event (death, intensive care unit admission, National Institute of Health Stroke Scale at discharge >3, CVT recurrence, major bleeding, or the presence of complications) occurred in 28.6% of patients (10 patients).Over the mean follow-up period of 3.3 years, 14.3% of the patients died (with only one death attributed to CVT), one patient experienced major bleeding, and no patients had a recurrence of CVT. CONCLUSIONS: In our cohort, CVT predominantly affected young women with at least one risk factor for its development. The presence of edema on CT and corticosteroid treatment were associated with a poor short-term prognosis. However, we observed a favorable long-term prognosis in terms of mortality, recurrence, and bleeding.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis de la Vena / Trombosis Intracraneal Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Rev Clin Esp (Barc) Año: 2023 Tipo del documento: Article País de afiliación: España Pais de publicación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis de la Vena / Trombosis Intracraneal Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Rev Clin Esp (Barc) Año: 2023 Tipo del documento: Article País de afiliación: España Pais de publicación: España